Nu Skin Enterprises, Inc. (NYSE:NUS - Get Free Report) insider Steven Keith Hatchett purchased 6,500 shares of the business's stock in a transaction on Wednesday, May 28th. The shares were acquired at an average price of $7.54 per share, with a total value of $49,010.00. Following the completion of the transaction, the insider now owns 162,065 shares of the company's stock, valued at approximately $1,221,970.10. This trade represents a 4.18% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Nu Skin Enterprises Trading Down 3.6%
NUS stock traded down $0.31 during trading on Monday, reaching $8.32. The company had a trading volume of 557,487 shares, compared to its average volume of 837,191. Nu Skin Enterprises, Inc. has a 52 week low of $5.32 and a 52 week high of $13.90. The company has a market cap of $411.07 million, a P/E ratio of -2.82 and a beta of 0.92. The business has a 50 day moving average of $6.65 and a 200 day moving average of $7.05. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. The business had revenue of $364.49 million for the quarter, compared to analysts' expectations of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. As a group, sell-side analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Shareholders of record on Friday, May 30th will be issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date of this dividend is Friday, May 30th. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -30.00%.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen raised shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research note on Monday, May 12th.
Check Out Our Latest Stock Report on Nu Skin Enterprises
Institutional Investors Weigh In On Nu Skin Enterprises
A number of hedge funds and other institutional investors have recently bought and sold shares of NUS. Meeder Asset Management Inc. purchased a new stake in Nu Skin Enterprises in the fourth quarter worth about $25,000. GAMMA Investing LLC grew its holdings in shares of Nu Skin Enterprises by 102.0% during the first quarter. GAMMA Investing LLC now owns 3,498 shares of the company's stock valued at $25,000 after buying an additional 1,766 shares during the last quarter. New York State Teachers Retirement System bought a new stake in shares of Nu Skin Enterprises during the first quarter valued at approximately $33,000. US Bancorp DE increased its position in shares of Nu Skin Enterprises by 424.2% during the fourth quarter. US Bancorp DE now owns 7,460 shares of the company's stock valued at $51,000 after acquiring an additional 6,037 shares in the last quarter. Finally, Public Employees Retirement System of Ohio increased its position in shares of Nu Skin Enterprises by 28.5% during the fourth quarter. Public Employees Retirement System of Ohio now owns 7,976 shares of the company's stock valued at $55,000 after acquiring an additional 1,768 shares in the last quarter. Hedge funds and other institutional investors own 82.84% of the company's stock.
Nu Skin Enterprises Company Profile
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.